Doctors should prescribe triptans for migraine patients who aren't receiving relief from over-the-counter (OTC) pain ...

For acute low back pain, there is moderate-certainty evidence that nonsteroidal anti-inflammatory drugs are an eff ...

The nonsteroidal anti-inflammatory drug (NSAID) flunixin meglumine has been approved by the FDA for fever associated with ...

The American College of Physicians strongly recommends adding a triptan to an NSAID to treat adults with moderate to severe ...

HealthDay News — People who take over-the-counter (OTC) pain relievers after a concussion may recover faster than those who do not, according to a study scheduled for presentation at the annual ...

Heading south for the winter? Oropouche virus, a new infectious disease, has been reported in travellers from Canada and the United States who visited Bolivia, Brazil, Peru, and Cuba. An article ...

Treatment with inebilizumab was associated with continued improvement in patients with AChR+ generalized myasthenia gravis, according to 52-week results from the MINT trial.

The American College of Physicians (ACP) has developed new recommendations for treatment of acute episodic migraines in nonpregnant adults in outpatient settings.

Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...

Use of OTC analgesics — including acetaminophen and NSAIDs — improves concussion symptoms and reduces recovery time in ...